ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
70,869.15
-0.82%
S&P 500
5,308.13
0.09%
Dow Jones
39,806.77
-0.49%
US Dollar vs Yen
156.4465
0.04%
Brent Oil
83.045
-0.58%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Ovid Therapeutics Inc (OVID)

  7. Ovid Therapeutics Inc (OVID) ニュース

OVID

Ovid Therapeutics (OVID)

Ovid Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:OVID
日付受信時刻ニュースソース見出しコード企業名
2024/05/1506 : 19Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:OVIDOvid Therapeutics Inc
2024/05/1421 : 11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OVIDOvid Therapeutics Inc
2024/05/1421 : 03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
2024/05/1421 : 00GlobeNewswire Inc.Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial ResultsNASDAQ:OVIDOvid Therapeutics Inc
2024/05/1320 : 00GlobeNewswire Inc.Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor ConferenceNASDAQ:OVIDOvid Therapeutics Inc
2024/04/0421 : 00GlobeNewswire Inc.Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:OVIDOvid Therapeutics Inc
2024/03/0822 : 24Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:OVIDOvid Therapeutics Inc
2024/03/0822 : 20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
2024/03/0822 : 00GlobeNewswire Inc.Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:OVIDOvid Therapeutics Inc
2024/02/2822 : 00GlobeNewswire Inc.Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care ConferenceNASDAQ:OVIDOvid Therapeutics Inc
2024/02/2708 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OVIDOvid Therapeutics Inc
2024/02/2708 : 01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OVIDOvid Therapeutics Inc
2024/02/2708 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OVIDOvid Therapeutics Inc
2024/02/2707 : 56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OVIDOvid Therapeutics Inc
2024/02/2707 : 53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OVIDOvid Therapeutics Inc
2024/02/1501 : 10Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OVIDOvid Therapeutics Inc
2024/02/1220 : 06Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OVIDOvid Therapeutics Inc
2024/02/0622 : 00GlobeNewswire Inc.Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:OVIDOvid Therapeutics Inc
2023/12/0707 : 08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
2023/12/0121 : 30GlobeNewswire Inc.Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)NASDAQ:OVIDOvid Therapeutics Inc
2023/11/1614 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:OVIDOvid Therapeutics Inc
2023/11/1606 : 11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:OVIDOvid Therapeutics Inc
2023/11/0405 : 08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:OVIDOvid Therapeutics Inc
2023/11/0321 : 13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OVIDOvid Therapeutics Inc
2023/11/0321 : 10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
2023/11/0321 : 00GlobeNewswire Inc.Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate UpdatesNASDAQ:OVIDOvid Therapeutics Inc
2023/10/1821 : 04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
2023/10/1821 : 00GlobeNewswire Inc.Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid’s Cash Runway into 2026NASDAQ:OVIDOvid Therapeutics Inc
2023/10/1021 : 00GlobeNewswire Inc.Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro SummitNASDAQ:OVIDOvid Therapeutics Inc
2023/10/0301 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:OVID

最近閲覧した銘柄

NYSE
NKE
Nike
USOTC
BNPQY
BNP Paribas (QX)
PM
XAUUSD
Gold vs US Dollar
COIN
BTCUSD
Bitcoin
USOTC
RHHBY
Roche (QX)
USI
USTECH100
US Tech 100
NYSE
MRK
Merck
NYSE
DIS
Walt Disney
NYSE
MCD
McDonalds
NYSE
XOM
Exxon Mobil
NASDAQ
AAPL
Apple
NYSE
CVX
Chevron
NYSE
AXP
American Express
CCOM
US500
US 500
NASDAQ
MSFT
Microsoft
USOTC
BASFY
BASF (QX)
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有